Improving follow-up care for abnormal colorectal cancer screenings
IMProving Adherence to Colonoscopy through Teams and Technology (IMPACTT)
This study is looking at ways to help more people get the follow-up colonoscopies they need after finding something unusual in their at-home stool tests for colorectal cancer, by figuring out what’s stopping them and making improvements in healthcare.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11030323 on NIH RePORTER |
What this research studies
This research focuses on enhancing the completion rates of follow-up colonoscopies after abnormal results from at-home stool tests for colorectal cancer screening. It aims to identify and address the various factors that prevent patients from receiving timely colonoscopy, including issues at the clinic, provider, and patient levels. By implementing targeted interventions and best practices within healthcare settings, the project seeks to improve care coordination and ultimately increase adherence to necessary follow-up procedures for vulnerable populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have received abnormal results from stool-based colorectal cancer screening tests and are at risk of not completing their follow-up colonoscopy.
Not a fit: Patients who have not undergone stool-based colorectal cancer screening or those who have already completed their follow-up colonoscopy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and prevention of colorectal cancer, significantly reducing mortality rates.
How similar studies have performed: Previous research has shown that targeted interventions can improve adherence to follow-up care in similar healthcare settings, indicating a promising approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Sarkar, Urmimala — University of California, San Francisco
- Study coordinator: Sarkar, Urmimala
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.